Mural Oncology plc (MURA) insider buying and SEC filings
Mural Oncology plc · CIK 1971543
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- L2
- Fiscal year end
- Dec 31
- Former names
- Mural Oncology Ltd
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$25K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Nov 10, 2025 | Planned (10b5-1) | Vicki L Goodman (Chief Medical Officer) sold 5,036 shares at $2.08 ($10K), marked as a 10b5-1 plan trade. Holdings down 6% to 84,727 shares. | SEC filing Filed Nov 10, 2025 |
| Nov 3, 2025 | Planned (10b5-1) | Adam D. Cutler (CFO) sold 7,148 shares at $2.09 ($15K), marked as a 10b5-1 plan trade. Holdings down 7% to 99,290 shares. | SEC filing Filed Nov 10, 2025 |
9 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow MURA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.